This Week in Nature

In an editorial, Nature announces that they will be introducing a creative commons license for the reuse of papers reporting full genome sequences. Under this license, non-commercial publishers may reuse the pdf and html versions of the article and other users may copy, distribute, and/or adapt the paper for non-commercial uses. This continues, the editors write, "[Nature's] drive to make papers as accessible as possible."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.